首页> Clinical lymphoma, myeloma & leukemia> Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study.

Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaoxian,Zhao

第一单位： Department of Pathology, Wake Forest University School of Medicine, Winston Salem, NC; Department of Laboratory Medicine, Cleveland Clinic, Cleveland OH.

作者： Xiaoxian,Zhao ^[1] ; Chad M,McCall ^[2] ; Jared G,Block ^[2] ; Sarah L,Ondrejka ^[3] ; Beenu,Thakral ^[4] ; Sa A,Wang ^[4] ; Yahya,Al-Ghamdi ^[5] ; Wayne,Tam ^[5] ; Brittany,Coffman ^[6] ; Kathryn,Foucar ^[6] ; Parnaz,Daneshpajouhnejad ^[7] ; Adam,Bagg ^[7] ; Feng,Lin ^[8] ; Eric D,Hsi ^[9]

作者单位： Department of Pathology, Wake Forest University School of Medicine, Winston Salem, NC; Department of Laboratory Medicine, Cleveland Clinic, Cleveland OH. ^[1] Carolinas Pathology Group, Charlotte, NC. ^[2] Department of Laboratory Medicine, Cleveland Clinic, Cleveland OH. ^[3] Department of Hematopathology, MD Anderson Cancer Center, Houston, TX. ^[4] Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York City, NY. ^[5] Department of Pathology, University of New Mexico, Albuquerque, NM. ^[6] Department of Pathology, University of Pennsylvania, Philadelphia, PA. ^[7] Department of Inflammation & Immunity, Cleveland Clinic, Cleveland OH. ^[8] Department of Pathology, Wake Forest University School of Medicine, Winston Salem, NC; Department of Laboratory Medicine, Cleveland Clinic, Cleveland OH; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. Electronic address: Hsi.Eric@mayo.edu. ^[9]

关键词 ANKL model Aggressive NK-Cell Leukemia/Lymphoma (ANKLL)CD6 CD6-ADC Extranodal NK/T-cell lymphoma (ENKTL)